Suggest an update

YC W20 · Active

Algen Biotechnologies

Using CRISPR to find treatments for cancer and inflammation

Class
Winter 2020
Status
Active
Industry
Healthcare
Location
San Francisco, CA, USA
Team size
15

Website

https://www.algenbio.com/

About

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.